Pharmaceutical Industry
China has trapped the tiger of AstraZeneca’s growth - Financial Times
Why Takeda no longer has an 'IT department' as part of the drug maker's digital and data transformation - Fortune
What the Trump administration could mean for the health care industry, from hospitals to pharma - STAT
The critical role of data integrity in ensuring pharmaceutical quality - News-Medical.Net
The Supreme Court Decisions Impacting Pharmacy Industry, Agency Interactions | ASPL 2024 - Drug Topics
The development of novel drugs: the role of lyophilization - Clinical Trials Arena
Navigating the Current Landscape for Pharma Leaders - Pharmaceutical Executive
Pfizer considers divestiture of hospital drugs business - Pharmaceutical Technology
Drugs Licensed
Medicaid Coverage of and Spending on GLP-1s - KFF
Novel Drug Approvals for 2023 - FDA.gov
Nurse's death linked to weight-loss drug Mounjaro approved on NHS - BBC.com
Daiichi Sankyo links up with Korea's Alteogen on subcutaneous Enhertu in $300M licensing deal - FiercePharma
Why is it so hard to get drugs approved for use during pregnancy? - The Conversation Indonesia
Thinking of buying Wegovy online? Here’s what to know about compounding pharmacies - NPR
Psychedelics: How Question 4 could legalize the drugs for therapeutic use in Mass. - WBUR News
Clinical Trials Underway for Cancer Drugs Licensed by Georgia State University - Georgia State University News
Two New Drugs Approved for Age-Related Macular Degeneration - Medscape
Drugs Patents
Why companies may want to accelerate marketing approval for their patented drugs in Canada - JD Supra
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink - FiercePharma
What really happens to drug prices when patents expire - STAT
Commentary: It's time for Congress to act on affordable prescriptions — Patricia Kelmar - Jacksonville Journal-Courier
Unfinished Business in Congress on Drug Patents and Competition - Crowell & Moring LLP
The Economics of Drug Discovery and the Impact of Patents - R Street
$52.6 Billion: Extra Cost to Consumers of Add-On Drug Patents - UCLA
How Asian pharma suppliers cash in on Ozempic copies - Reuters
Lipella Pharma Secures Key Patent for Liposomal Platform, Extends Drug Pipeline Protection to 2035 | LIPO Stock News - StockTitan
Drugs Generics
Generic Drugs Market Research Report 2024: Patent - GlobeNewswire
What to know about brand-name and generic drugs - Parkview Health
Why do hospitals keep running out of generic drugs? : Planet Money - NPR
Walgreens agrees to pay $100 mln to resolve lawsuit over generic drug pricing - Reuters
Industrial Policy To Reduce Prescription Generic Drug Shortages - Center For American Progress
Advancing Generic Drug Development: Translating Science to Approval 2024 - 09/24/2024 - FDA.gov
The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat - STAT
Branded vs. generic U.S. drug prescriptions dispensed 2005-2021 - Statista
Generic drugs in the U.S. face new economic pressures 40 years on - Marketplace
FDA Food and Drug Administration
Robert F. Kennedy Jr.’s FDA Wish List: Raw Milk, Stem Cells, Heavy Metals - The New York Times
US FDA approves PTC Therapeutics' gene therapy for ultra-rare disorder - Reuters
Outgoing FDA head warns of sweeping policy changes in second Trump term - The Guardian US
Nearly 80,000 pounds of Costco butter recalled for missing 'Contains Milk statement': FDA - USA TODAY
FDA adds new warning to weight loss drugs - Boston Herald
FDA announces common over-the-counter cough and cold medicine doesn't work - KOMO News
FDA to Finally Ban Controversial Ingredient in Popular Decongestants - ScienceAlert
FDA commissioner suggests RFK Jr. and Trump might compromise an agency ‘at peak performance’ - STAT
FDA hits Kezar's zetomipzomib program with 2nd clinical hold in 2 months - Fierce Biotech
Pharmaceutical Companies
Why Takeda no longer has an 'IT department' as part of the drug maker's digital and data transformation - Fortune
What Might the Future of Prescription Drugs Look Like Under Trump? - MedCity News
OpenAI isn’t built for health care. So why is its tech already in hospitals, pharma, and cancer care? - STAT
Drug companies found liable in Baltimore’s opioid crisis, must pay $266M in damages - The Baltimore Banner
BioNTech strikes $950mn deal for Chinese drugmaker Biotheus - Financial Times
Yale spin-off company Modifi Bio acquired by Merck in multimillion dollar deal - Yale Daily News
The critical role of data integrity in ensuring pharmaceutical quality - News-Medical.Net
Navigating the Current Landscape for Pharma Leaders - Pharmaceutical Executive
Schrödinger announces collaboration with Novartis - The Pharma Letter
Retail Pharmacies
Four ways retail pharmacies are evolving for a safer, digital future - Wolters Kluwer
More Minnesotans face ‘pharmacy deserts’ with chain drugstore closures - Star Tribune
Behold, the Pharmacy of the Future - Food Institute Blog
Green Line Apothecary is closing its pharmacy business. Here's what comes next for them. - The Providence Journal
A bitter pill: As pharmacies shutter, Pitt experts wonder about the impact on access - Pittsburgh Post-Gazette
Why should patients seek vaccinations from family physicians over retail pharmacies? - Medical Economics
Mpox vaccine now available at UK Retail Pharmacies - UKNow
Tips for Easing the Sterile Compounding Staffing Crisis - Pharmacy Practice News
H+H plans retail pharmacies at Harlem, Jacobi locations - Crain's New York Business
Drug Marketing
Mothers Against Prescription Drug Abuse: Healthcare Marketing Impact Awards 2024 - Modern Healthcare
Otsuka falls foul of most serious drug marketing breach, again, as Jinarc training site comes under fire - FiercePharma
Integrated Safety Analyses in Drug Marketing Applications: Avoiding Common Mistakes - 03/07/2024 - FDA.gov
FDA to pull common but ineffective cold medicine from market - CBS News
6 things you should know about drug marketing authorizations (MA) - Servier
Senators target false prescription medication marketing on social media with new bill - The Hill
Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals - Pharmaceutical Technology
Torrid market for copycat weight loss drugs could be short-lived - NPR
FDA Rejects Application for Psychedelic Drug - Holland & Knight